Le Lézard
Classified in: Health
Subject: SVY

$67B+ Ophthalmic Devices Market Analysis (2015-2026) Featuring Alcon Labs, Carl Zeiss, Topcon, Valeant Pharma, Iridex, Ellex Medical Lasers, Escalon Medical, and Second Sight Medical Products


DUBLIN, Jan. 27, 2020 /PRNewswire/ -- The "Ophthalmic Devices Market Global Forecast by Application, Products, Regions, Companies" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

Global Ophthalmic Device Market is Projected to Reach More Than US$ 67 Billion by the End of 2026

The key drivers of global ophthalmic device market are; growing aging population, rapid technological advancements, increasing awareness of eye care products, several initiatives to spread awareness, increasing large pool of patients with eye diseases, and changing demographics and geographical trends, and more and more adoption of digital devices is expected to full fill the growth of global ophthalmic device market. The major factors that restrain the market growth are; slow pipeline of ophthalmology drugs as well as global economic slowdown.

Besides, growing awareness of eye diseases in developed and developing countries such as the United States, China, India, Europe, Japan, the United Kingdom, France, and Germany is expected to provide significant growth opportunities in this market. Around the world, various government initiatives to control visual impairment and increasing adoption of contact lenses and spectacles in devices are another factor driving the market.

This report also covers the recent study of new technology used in fundus cameras like "Volk iNview" by ophthalmologists. This new ophthalmic camera device can capture the images of fundus using an Apple iPhone or iPod, iPhone 6 & 6S, iPhone 5S, and iPod Touch and many new technologies on all platforms have been studied extensively in this study.

By Application - Vision Care products is dominating Market Share in Overall Global Ophthalmic Devices Market

The major segment that holds the largest market share is vision care followed by surgical instrument products. This report fragmented by application into three major parts; Diagnostics & Monitoring devices market, Surgical Instruments market and vision care. Again these major segments are classified into sub segments.

By Region - North America is the leading Market

In this report, full regional details are provided along with their regional factors and challenges faced by each regions. The global ophthalmic device are fragmented by regional profiles into four parts; Asia-Pacific, Europe, North America and Rest of the World. North America will dominate the market.

Key Topics Covered

1. Executive Summary

2. Global Ophthalmic Devices Market

3. Market Share - Global Ophthalmic Devices (2015 - 2026)
3.1 By Application
3.2 By Products (Devices)
3.3 By Regions

4. Market Analysis - By Application (2015 - 2026)
4.1 Diagnostics & Monitoring Devices
4.2 Surgical Instruments Devices
4.3 Vision Care Products

5. Market Analysis - By Diagnostics & Monitoring Devices (2015 - 2026)
5.1 Fundus Camera
5.2 Optical Coherence Tomography Scanner
5.3 Tonometer Market
5.4 Others

6. Market Analysis - Surgical Instruments Devices (2015 - 2026)
6.1 Refractive Error Surgery Devices
6.2 Glaucoma Surgery Devices
6.3 Cataract Surgery Devices
6.4 Retinal Surgery Devices

7. Market Analysis - Vision Care Products (2015 - 2026)
7.1 Contact Lenses Market
7.2 Others

8. By Region - Global Ophthalmic Devices Market (2015 - 2026)
8.1 Asia-Pacific
8.2 North America
8.3 Europe
8.4 Rest of the World (RoW)

9. Alcon Laboratories, Inc. - Company Analysis
9.1 Company Overview
9.2 Strategy
9.2.1 Point A - Alcon to Launch PRECISION1 Daily Disposable Contact Lenses as it Continues to Deliver on Vision Care Pipeline
9.2.2 Point B - Alcon Introduces AcrySof IQ PanOptix Trifocal IOL in the U.S., the First and Only FDA-Approved Trifocal Lens
9.2.3 Point C
9.3 Mergers/ Acquisitions
- In 2018: Alcon Announces Acquisition of Tear Film Innovations, Inc.
- In 2019: Alcon Acquires PowerVision for $285 Million.
9.4 Company Sales

10. Carl Zeiss - Company Analysis
10.1 Company Overview
10.2 Marketing Strategy
10.2.1 Point A
10.2.2 Point B
10.2.3 Point C
10.3 Merger & Acquisitions
10.4 Company Sales

11. Topcon Corporation - Company Analysis
11.1 Company Overview
11.2 Marketing Strategy
11.2.1 Point A
11.2.2 Point B
11.2.3 Point C
11.3 Merger & Acquisitions
11.4 Company Sales

12. Valeant Pharmaceuticals International, Inc. - Company Analysis
12.1 Company Overview
12.2 Marketing Strategy
12.2.1 Point A
12.2.2 Point B
12.2.3 Point C
12.3 Merger/ Acquisitions
12.4 Company Sales

13. Iridex Corporation - Company Analysis
13.1 Company Overview
13.2 Strategy
13.2.1 Point A
13.2.2 Point B
13.2.3 Point C
13.3 Company Sales

14. Ellex Medical Lasers - Company Analysis
14.1 Company Overview
14.2 Strategy
14.2.1 Point A
14.2.2 Point B
14.3 Merger & Acquisitions
14.4 Company Sales

15. Escalon Medical - Company Analysis
15.1 Company Overview
15.2 Strategy
15.2.1 Point A
15.2.2 Point B
15.3 Merger & Acquisitions
15.4 Company Sales

16. Second Sight Medical Products Inc. - Company Analysis
16.1 Company Overview
16.2 Strategy
16.2.1 Point A
16.2.2 Point B
16.3 Company Sales

17. Growth Drivers
17.1 Rising Incidence of Eye-related Disorders and Ocular Defects
17.2 Technological Innovations in Ophthalmic Devices
17.3 Increasing Prevalence of Eye Disorder
17.4 Increasing Prevalence of Lifestyle-associated Diseases

18. Challenges
18.1 Lack of Awareness among People about Eye Disorders
18.2 Shortage of Trained Ophthalmologists/ Human Resources
18.3 Poor Primary Healthcare Infrastructure
18.4 Lack of Healthcare Insurance

For more information about this report visit https://www.researchandmarkets.com/r/5pk8qj

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.


Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]   

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

at 03:47
Zest Dental Solutions, a global leader in innovative dental solutions proudly announces a strategic partnership with The Pathway. Founded by Justin Moody, DDS and based in Arizona, The Pathway is a continuing education program that teaches dentists...

at 03:34
Medivir AB (STO: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today that its selective cathepsin K inhibitor, MIV-711, has been granted Rare Pediatric Disease...

at 03:16
First quarter Net sales reached SEK 9.4 (13.0) million.The operating result totaled SEK -18.4 (-14.4) million.Earnings per share, basic and diluted, were SEK -0.11 (-0.09).Cash flow from operating activities totaled SEK -7.3 (-12.2) million.CEO...

at 03:03
International medical imaging IT and cybersecurity company Sectra (STO: SECT B) will provide its platform for medical education, Sectra Education Portal, to four university colleges in Denmark. With the solution, they aim to elevate the educational...

at 03:00
Sentrycs, a leading innovator in adaptive counter-drone solutions, is proud to announce its inclusion in the prestigious UK National Protective Security Authority Catalogue of Security Equipment (NPSA CSE).  ...

at 02:22
Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the first quarter 2024 First Quarter 2024 Total revenue increased 19 per cent, 20 per cent at constant exchange rates, (CER)1, to SEK 6,256 M (5,239)Haematology revenue...



News published on and distributed by: